Literature DB >> 24365346

Neurotoxicity of commonly used hepatic drugs.

Christine L Ahrens1, Edward M Manno2.   

Abstract

Neurologic complications are common side-effects of immunosuppressive medications used in the prevention of graft rejection after organ transplantation. The medications most commonly encountered include the calcineurin inhibitors and mycophenolate mofetil. Depression is the most commonly encountered neurotoxicity; however, severe but rare adverse neurological effects related to these therapies have been reported. Interferons, ribavirin, and protease inhibitors are therapeutic options commonly encountered in the treatment of hepatitis. Nucleoside analogs such as adefovir dipivoxil and entecavir carry significant risks for the development of lactic acidosis and hepatic dysfunction; however, most common adverse effects to these therapies in general are mild. While the mechanisms of action are poorly elucidated, they are discussed along with treatment strategies.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Neurotoxicity; calcineurin inhibitors; chronic hepatitis; depression; immunosuppresants; interferons; protease inhibitors; ribavirin

Mesh:

Substances:

Year:  2014        PMID: 24365346     DOI: 10.1016/B978-0-7020-4087-0.00046-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  4 in total

1.  Neurologic Complications of Common Variable Immunodeficiency.

Authors:  Jenna Thuc-Uyen Nguyen; Ari Green; Michael R Wilson; Joseph L DeRisi; Katherine Gundling
Journal:  J Clin Immunol       Date:  2016-10-04       Impact factor: 8.317

Review 2.  Neurologic manifestations of gastrointestinal and liver diseases.

Authors:  José M Ferro; Sofia Oliveira
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

Review 3.  Management of Neurologic Manifestations in Patients with Liver Disease.

Authors:  José M Ferro; Pedro Viana; Patrícia Santos
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.598

4.  Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study.

Authors:  Sofia Volpato; Sara Montagnese; Alberto Zanetto; Matteo Turco; Michele De Rui; Alberto Ferrarese; Piero Amodio; Giacomo Germani; Marco Senzolo; Martina Gambato; Francesco Paolo Russo; Patrizia Burra
Journal:  BMJ Open Gastroenterol       Date:  2017-12-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.